human
lower
respiratori
tract
consid
steril
normal
healthi
individu
flanagan
et
al
speert
despit
fact
everi
day
breath
multipl
microorgan
present
air
aspir
thousand
organ
mouth
nasopharynx
appar
steril
maintain
numer
interrel
compon
lung
physic
structur
mucociliari
elev
compon
innat
adapt
immun
system
discuss
review
diamond
et
al
gerritsen
howev
possibl
observ
steril
might
result
laboratori
practic
appli
studi
flora
lung
histor
research
face
set
diseas
character
chang
larg
cryptic
lung
microbiom
lack
tool
studi
lung
ecolog
whole
concentr
familiar
cultivat
candid
pathogen
avail
new
technolog
cultivationindepend
analysi
microbi
popul
possibl
follow
individu
sampl
lung
microbiom
sequenti
episod
diseas
recoveri
order
identifi
associ
lung
microbiom
health
diseas
respir
contamin
particl
pathogen
evad
lung
physic
immun
barrier
usual
elimin
dendrit
cell
alveolar
macrophag
deliv
local
drain
lymph
node
macrophag
kill
invad
microorgan
en
rout
drain
lymph
node
case
node
bozza
et
al
kirbi
et
al
thu
unusu
isol
viabl
bacteria
fungi
normal
lung
tissu
lassflorl
et
al
term
steril
appli
caution
perhap
accur
say
resid
flora
perman
colon
normal
lung
even
normal
healthi
lung
microb
free
time
lower
airway
infect
bacteria
virus
fungi
among
preval
caus
transmiss
diseas
human
two
three
million
communityacquir
nonhospitalacquir
case
per
year
unit
state
segreti
et
al
number
death
attribut
pneumonia
bacteri
viral
influenza
unit
state
gao
et
al
http
wwwcdcgovnchsfastatsdeathshtm
nearli
million
new
case
tuberculosi
report
around
world
http
proper
treatment
lung
individu
infecti
diseas
revert
normal
steril
state
littl
known
composit
microbi
popul
upper
lower
airway
health
diseas
like
given
multipl
microorgan
alreadi
implic
chronic
lung
diseas
chronic
obstruct
pulmonari
diseas
copd
undetect
organ
complex
relationship
multipl
pathogen
involv
current
understood
studi
examin
microbi
speci
limit
number
normal
subject
patient
variou
respiratori
disord
one
studi
use
rdna
clone
librari
microarray
detect
bacteria
lung
patient
without
respiratori
diseas
briefli
intub
surgeri
flanagan
et
al
studi
report
patient
intub
longer
period
detect
rdna
bacteri
divers
present
decreas
antibiot
usag
anoth
studi
use
rdna
amplif
identifi
bacteri
speci
patient
ventilatorassoci
pneumonia
bahranimougeot
et
al
studi
identifi
bacteri
pathogen
seen
use
convent
cultur
techniqu
especi
anaerob
found
oral
bacteria
could
detect
lung
one
studi
sputum
sampl
cystic
fibrosi
cf
patient
analyz
use
gene
profil
author
identifi
averag
speci
present
per
subject
bittar
et
al
virus
also
examin
nasal
lavag
asthmat
normal
subject
cold
symptom
use
virochip
microarray
kistler
et
al
microarray
technolog
identifi
virus
convent
cultur
method
excel
sensit
specif
compar
pathogenspecif
polymeras
chain
reaction
pcr
unexpect
divers
human
coronaviru
rhinoviru
strain
discov
subject
lung
gener
steril
individu
becom
chronic
colon
organ
colon
lung
physic
compromis
airway
immun
system
defici
subject
chronic
microbi
colon
airway
highfrequ
episod
viral
bacteri
fungal
lower
respiratori
infect
perhap
bodi
site
direct
relationship
diseas
microbiom
explicit
lung
distinct
obviou
microbi
differ
normal
diseas
individu
lower
respiratori
tract
compos
trachea
lung
quit
differ
structur
function
upper
respiratori
tract
highli
colon
microorgan
lung
divid
differ
section
accord
function
structur
bronchi
bronchiol
alveoli
bronchi
bronchiol
primarili
conduct
airway
surround
thick
cartilag
allow
easi
airflow
parenchyma
alveolar
tissu
lung
ga
exchang
occur
conduct
airway
cover
ciliat
epithelium
interspers
differ
type
secretori
cell
releas
mucin
immunomodulatori
protein
surfact
proteas
togeth
physic
chemic
barrier
protect
physic
biolog
damag
establish
mucociliari
elev
bring
upward
transport
mucu
stream
lung
fraser
secretori
cell
decreas
proport
trachea
less
distal
alveolar
part
lung
addit
physicochem
protect
provid
cilia
mucu
epithelium
also
protect
sever
immun
cell
includ
dendrit
langerhan
lymphocyt
mast
cell
respond
inhal
antigen
establish
robust
immun
fraser
thought
conjunct
physic
barrier
provid
nose
upper
respiratori
mucosa
defens
enough
maintain
steril
lower
respiratori
tract
vast
major
lung
surfac
epithelium
howev
alveolar
estim
total
volum
lung
alveolar
tissu
remaind
ga
stone
et
al
primari
role
tissu
carri
ga
exchang
epithelium
mostli
continu
singl
layer
cell
overli
thin
interstitium
contain
numer
capillari
suppli
ampl
blood
ga
exchang
fraser
stone
et
al
unlik
epithelium
conduct
airway
respiratori
epithelium
ciliat
protect
mucu
instead
cover
surfact
protein
maintain
surfac
tension
effici
ga
exchang
lack
mucu
secretori
cell
compens
presenc
alveolar
macrophag
mast
cell
lymphocyt
dendrit
cell
monocytelik
cell
protect
epithelium
potenti
pathogen
help
maintain
steril
recent
world
health
organis
figur
rank
lower
respiratori
diseas
second
assess
burden
diseas
worldwid
http
wwwwhointrespiratoryen
peopl
die
us
due
chronic
lower
respiratori
diseas
http
wwwcdcgovnchsfastatsdeathshtm
chronic
respiratori
diseas
includ
asthma
copd
cf
bronchiectasi
diseas
gener
lead
impair
clearanc
function
mucociliari
elev
andor
immun
protect
lung
addit
immun
defici
caus
human
immunodefici
viru
hiv
also
disrupt
typic
immun
homeostasi
lung
without
normal
protect
barrier
lung
fall
victim
persist
sever
colon
ultim
lead
death
particularli
cf
patient
discuss
lung
microbiom
diseas
differ
normal
individu
data
discuss
follow
section
demonstr
clear
link
microbi
colon
sever
diseas
symptom
unclear
howev
exact
role
differ
microbi
popul
play
initi
enhanc
progress
chronic
respiratori
diseas
lastli
case
data
hint
popul
structur
might
actual
protect
declin
much
research
need
conduct
area
make
definit
claim
chapter
discuss
method
sampl
character
microbiom
lung
addit
review
current
statu
understand
lung
microbiom
asthma
idiopath
bronchiectasi
cf
copd
immun
defici
due
hiv
infect
sever
procedur
develop
sampl
microbi
popul
human
lung
econich
order
increas
invas
sputum
induct
bronchoalveolar
lavag
bal
bronchial
brush
endobronchi
biopsi
transbronchi
biopsi
sputum
induct
inhal
hyperton
salin
noninvas
method
obtain
sampl
lower
respiratori
tract
cell
microbi
analysi
bickerman
et
al
qualiti
sampl
vari
score
volum
obtain
sputum
plug
level
salivari
contamin
measur
squamou
cell
observ
microscopi
bal
procedur
bronchoscop
pass
mouth
nose
lung
salin
instil
segment
lung
recollect
examin
henderson
reynold
chretien
bal
commonli
use
diagnos
infect
immunocompet
immunosuppress
patient
bal
common
procedur
sampl
lower
respiratori
system
microbi
colonizationinfect
statu
sampl
compon
epitheli
line
fluid
determin
protein
composit
airway
often
use
evalu
patient
lung
immunolog
statu
sampl
cell
pathogen
level
bal
invas
procedur
thu
less
ideal
research
purpos
bronchial
brush
provid
access
cell
microb
adher
lumin
surfac
lower
airway
procedur
flexibl
fiber
optic
bronchoscop
use
brush
target
lesion
site
fennessi
zavala
et
al
induc
sputum
bal
procedur
allow
sampl
cell
microb
wash
lumen
surfac
brush
recov
adher
cell
eg
bronchial
epitheli
cell
microb
recent
brush
techniqu
develop
sampl
distal
lung
ie
small
airway
epitheli
cell
associ
microb
ammou
et
al
techniqu
enabl
investig
studi
microbiom
lung
diseas
copd
endobronchi
biopsi
involv
use
fiber
optic
bronchoscop
identifi
appropri
target
site
lung
obtain
larg
airway
tissu
sampl
use
insert
allig
forcep
cup
forcep
curett
pass
endoscop
central
channel
procedur
pose
higher
risk
bal
allow
sampl
invas
microb
within
airway
tissu
scott
et
al
trulock
et
al
transbronchi
biopsi
invas
sampl
procedur
routin
perform
clinic
care
allow
clinician
research
obtain
distal
small
airway
tissu
well
alveolar
tissu
procedur
safe
done
sever
research
group
balzar
et
al
like
understand
microbiom
human
distal
lung
tissu
carri
signific
risk
complic
standard
microbiolog
virolog
method
detect
small
proport
bacteria
virus
present
variou
bodi
site
great
major
organ
uncharacter
uncultiv
understand
real
divers
cultureindepend
method
sequenc
thu
necess
sequencedbas
identif
microbi
speci
facilit
decreas
cost
sequenc
avail
nextgener
sequenc
technolog
enhanc
capac
gener
larg
amount
data
identif
bacteri
speci
within
environ
amplif
rrna
gene
rdna
use
univers
primer
use
divers
character
genet
locu
present
bacteri
speci
relman
et
al
nine
hypervari
region
rdna
use
bacteri
speci
identif
chakravorti
et
al
roka
et
al
region
better
discriminatori
valu
other
sequenc
phylogenet
analysi
bacteri
rrna
deriv
microbiom
sampl
primari
method
use
investig
bacteri
divers
human
bodi
bik
et
al
dekio
et
al
eckburg
et
al
gao
et
al
hugenholtz
et
al
hyman
et
al
zhang
et
al
studi
reveal
far
higher
level
divers
convent
cultur
techniqu
ali
et
al
bik
et
al
dekio
et
al
kazor
et
al
kort
et
al
kroe
et
al
paster
et
al
studi
reveal
major
bacteri
sequenc
correspond
uncultiv
speci
novel
organ
signific
intersubject
variabl
variabl
stool
mucos
microbi
popul
exampl
recent
studi
blaser
colleagu
new
york
univers
demonstr
substanti
chang
ratio
genu
streptococcu
propionibacterium
skin
sampl
healthi
person
normal
skin
patient
psoriasi
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
textrm
ratio
textrm
n
textrm
clone
end
document
psoriat
lesion
sampl
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
textrm
ratio
textrm
n
textrm
clone
p
textrm
end
document
gao
et
al
lung
studi
bacteri
divers
analyz
endotrachael
aspir
seven
intub
patient
colon
pseudomona
aeruginosa
use
sequenc
rrna
clone
librari
oligonucleotid
microarray
term
phylochip
flanagan
et
al
control
subject
briefli
intub
elect
surgeri
bacteria
detect
either
method
sampl
control
sequenc
clone
librari
detect
presenc
mani
oral
nasal
gastrointestin
associ
bacteria
includ
known
pathogen
phylochip
detect
organ
mani
addit
bacteri
group
present
low
abund
follow
antibiot
therapi
bacteri
popul
divers
decreas
domin
singl
respiratori
pathogen
six
seven
patient
domin
speci
p
aeruginosa
spite
target
organ
antibiot
reportedli
sensit
author
hypothes
loss
popul
divers
may
directli
contribut
pathogen
persist
develop
pneumonia
similarli
amplif
region
intern
transcrib
spacer
region
rrna
conserv
fungal
gene
allow
discrimin
fungal
speci
fujita
et
al
makimura
preliminari
studi
undertaken
examin
efficaci
commun
sequenc
method
identifi
fungal
speci
bal
lung
sampl
human
subject
fungal
region
amplifi
result
show
patient
fungal
dna
level
could
reproduc
detect
pcr
detect
fungi
includ
aspergillu
fumigatu
candida
tropicali
penicillium
digitatum
among
other
den
unpublish
data
agre
culturebas
studi
show
sampl
popul
evid
pulmonari
fungal
colon
lassflorl
et
al
commonli
fumigatu
candida
speci
also
zygomycet
result
also
demonstr
rrna
sequenc
viabl
platform
character
fungal
commun
human
bodi
although
conserv
gene
target
determin
viral
divers
whole
genom
shotgun
sampl
enrich
virus
filter
lead
effect
character
viral
commun
angli
et
al
hundr
viral
genom
sequenc
complet
singl
sequenc
reaction
run
use
gsflx
sequenc
platform
use
technolog
random
primingbas
method
refer
sequenc
independ
singl
primer
amplif
sispa
nearfulllength
genom
rna
dna
virus
sequenc
sispa
use
sequenc
known
unknown
viral
genom
djikeng
et
al
viral
sequenc
methodolog
potenti
adapt
determin
virus
within
bal
enrich
use
nucleas
treatment
filtrat
follow
take
extract
total
rna
dna
sispa
process
follow
sequenc
comparison
known
virus
initi
studi
small
rrna
describ
hint
great
divers
within
human
microbiom
yet
left
import
question
unansw
ident
nondomin
commun
member
biolog
role
applic
shotgun
techniqu
studi
human
microbiom
kurokawa
et
al
manichanh
et
al
zhang
et
al
highlight
extent
microbi
divers
associ
human
bodi
reveal
much
ident
biolog
noncultur
microorgan
result
reduc
cost
improv
sequenc
technolog
possibl
perform
indepth
metagenom
survey
human
bodi
microbi
divers
beyond
rrna
survey
metagenom
term
introduc
describ
function
sequencebas
analysi
total
microbi
genom
environment
sampl
handelsman
et
al
metagenom
use
techniqu
resembl
whole
genom
shotgun
approach
singl
genom
sequenc
limit
singl
speci
human
metagenom
provid
insight
complex
composit
microbiom
sever
bodi
site
inform
allow
us
draw
tent
conclus
relationship
specif
microbiom
health
human
microbiom
compos
multipl
ecolog
nich
includ
mouth
kroe
et
al
paster
et
al
esophagu
zhang
et
al
stomach
bik
et
al
intestin
gill
et
al
skin
gao
et
al
vagina
zhou
et
al
understand
overlap
degre
commun
rudimentari
best
perhap
extens
studi
human
gut
microbiom
interact
gut
microflora
independ
interact
genet
makeup
host
play
role
obes
crohn
diseas
ulcer
coliti
frank
et
al
gophna
et
al
turnbaugh
et
al
asthma
exacerb
long
associ
viral
infect
pattemor
et
al
recent
use
revers
transcriptas
pcr
greatli
facilit
identif
exacerbationassoci
viru
studi
use
tool
suggest
asthma
exacerb
caus
viru
infect
wark
et
al
rhinoviru
rv
infect
earli
childhood
associ
develop
asthma
lower
respiratori
tract
infect
wheez
jackson
et
al
lemansk
et
al
also
associ
hospit
asthma
adult
venarsk
et
al
separ
studi
reveal
patient
allerg
asthma
infect
rv
increas
admiss
hospit
dust
mite
allergen
primari
allergen
patient
skin
test
panel
aeroallergen
green
et
al
respiratori
syncyti
viru
rsv
infant
caus
lower
respiratori
infect
lead
pneumonia
bronchiol
rsv
bronchiol
lead
caus
wheez
infant
young
children
children
infect
rsv
result
bronchiol
like
develop
wheez
asthma
later
childhood
peebl
similarli
human
metapneumoviru
hmpv
first
isol
children
found
associ
asthma
exacerb
children
year
age
adult
foulongn
et
al
william
et
al
mycoplasma
pneumonia
chlamydia
pneumonia
bacteria
attach
airway
epitheli
cell
caus
cell
damag
infect
bacteria
shown
associ
asthma
exacerb
johnston
martin
lieberman
et
al
martin
et
al
use
pcr
assay
patient
asthma
posit
either
bacteria
lung
tissu
bal
suggest
level
colon
bacteria
may
common
asthma
patient
martin
et
al
studi
mous
model
suggest
preexist
allerg
inflamm
impair
abil
upregul
lung
lead
decreas
clearanc
pneumonia
increas
airway
inflamm
kraft
et
al
evid
accumul
infect
associ
induct
develop
asthma
first
longterm
cohort
studi
develop
asthma
show
childhood
asthma
begin
infanc
first
episod
wheez
begin
age
frequent
associ
lower
respiratori
tract
viral
infect
usual
rsv
also
rv
gern
et
al
sigur
et
al
infecti
episod
associ
wheez
strong
predictor
develop
childhood
asthma
atopi
devulap
et
al
kusel
et
al
martinez
et
al
singh
et
al
second
mani
studi
associ
viral
infect
asthma
preval
children
devulap
et
al
jackson
et
al
kusel
et
al
papadopoulo
kalobats
sigur
et
al
singh
et
al
william
et
al
lastli
wu
et
al
provid
evid
suggest
viral
infect
causal
role
asthma
initi
develop
show
viral
infect
first
month
age
strongli
correl
develop
asthma
age
wu
et
al
onethird
children
childhood
wheez
asthma
howev
develop
persist
asthma
symptom
adulthood
gerritsen
taylor
et
al
vonk
et
al
manag
symptom
corticosteroid
therapi
effect
may
alter
asthma
progress
guilbert
et
al
role
infect
asthma
induct
develop
like
shown
mediat
effect
infect
chronic
inflammatori
respons
airway
asthmat
microbi
infect
gener
either
respons
could
exacerb
attenu
asthma
respect
asthmat
proinflammatori
respons
persist
even
absenc
allergen
involv
cell
eosinophil
mast
cell
cytokin
holgat
bacteri
infect
shown
contribut
asthma
develop
longitudin
prospect
birth
cohort
studi
infant
born
mother
current
previou
asthma
neonat
colon
hypopharyng
region
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
combin
organ
found
increas
risk
recurr
wheez
earli
childhood
asthma
age
bisgaard
et
al
protect
role
bacteria
report
blaser
et
al
sever
studi
found
protect
effect
mycobacteri
exposur
atopi
airway
inflamm
camporota
et
al
shirakawa
et
al
yang
et
al
exposur
includ
bacillu
calmetteguerin
vaccin
heatkil
mycobacterium
vacca
earli
exposur
bacteri
endotoxin
may
reduc
futur
allergi
asthma
von
mutiu
et
al
although
endotoxin
associ
hous
dust
associ
asthma
symptom
wors
lung
function
dale
et
al
michel
et
al
park
et
al
thu
role
bacteria
asthma
initi
develop
appear
complex
caus
interact
like
prove
interact
bacteria
bacteri
compon
modul
innat
immun
system
respons
character
interact
complic
time
dose
anatom
site
durat
bacteri
exposur
well
host
genet
environment
factor
influenc
immun
inflammatori
respons
holt
recent
demonstr
patient
sever
asthma
also
atop
sensit
environment
fungi
may
benefit
treatment
antifung
azol
itraconazol
den
et
al
observ
rais
question
relationship
among
asthma
sever
fungal
sensit
fungal
exposur
issu
complic
million
speci
fungi
thought
exist
hawksworth
rossman
speci
fungi
associ
symptom
airway
allergi
horner
et
al
one
speci
fumigatu
allergen
thought
particip
human
airway
allergi
http
wwwallergomeorg
determin
clinic
relev
fungal
allergen
confound
extens
crossreact
among
fungal
allergen
crameri
et
al
fungal
allergen
induc
number
differ
human
bronchopulmonari
disord
distinct
immun
pathogenesi
allerg
bronchopulmonari
aspergillosi
abpa
respiratori
system
chronic
colon
typic
fumigatu
evid
suggest
sever
asthmat
without
abpa
like
atop
fungi
patient
milder
diseas
diagnost
label
sever
asthma
fungal
sensit
saf
recent
appli
group
den
et
al
patient
fungal
sensit
commonli
fumigatu
candida
albican
penicillium
notatum
driscol
et
al
associ
sever
asthma
fungi
identifi
numer
studi
atopi
environment
fungi
associ
sever
asthma
driscol
et
al
mani
popul
studi
shown
associ
local
fungal
spore
count
medic
emerg
due
asthma
exacerb
atkinson
et
al
furthermor
studi
shown
fungu
exposur
fungalsensit
individu
induc
asthma
symptom
mall
matheson
et
al
pulimood
et
al
salo
et
al
woodcock
et
al
treatment
patient
saf
antifung
drug
gener
led
improv
asthma
symptom
den
et
al
concurr
improv
sever
marker
atopi
reduc
ige
valu
reduc
eosinophil
count
reduct
level
dose
oral
system
steroid
requir
pasqualotto
et
al
find
lead
consider
fungal
composit
lung
microbiom
asthmat
individu
inde
normal
individu
environment
fungi
colon
lung
otherwis
healthi
peopl
lassflorl
et
al
okudaira
et
al
studi
depend
cultivationbas
method
detect
identif
fungi
cultivationindepend
method
ga
chromatographymass
spectroscopi
exhal
breath
reveal
presenc
fungu
specif
biomark
patient
cf
without
fungal
colon
fumigatu
syhr
et
al
approach
limit
analyz
known
fumigatu
marker
applic
sequencingbas
approach
studi
lung
microbiom
essenti
reveal
role
fungi
lung
microbiom
role
lung
microbiom
asthma
cf
common
inherit
lung
diseas
world
sever
autosom
recess
diseas
incid
birth
popul
northwestern
european
origin
mutant
gene
carrier
frequenc
popul
genet
defect
occur
cystic
fibrosi
transmembran
regul
cftr
protein
act
transport
chlorid
across
cell
membran
patient
cf
archetyp
popul
chronic
bronchial
colon
symptom
includ
perman
bacteri
colon
lower
airway
format
biofilm
fat
maldigest
male
infertil
elev
level
chlorid
sweat
knowl
duri
thick
pulmonari
system
mucu
cf
patient
minim
effect
mucociliari
elev
clear
lung
mucustrap
microorgan
debri
consequ
microb
chronic
colon
patient
lung
suffer
bout
infect
requir
frequent
hospit
admiss
cultur
reveal
wide
rang
bacteria
includ
p
aeruginosa
mycobacteria
fumigatu
sometim
virus
precis
contribut
differ
microb
patient
morbid
import
interspecif
interact
remain
larg
unclear
review
harrison
complex
ecosystem
difficult
overst
exampl
complex
lung
cf
patient
contain
larg
number
neutrophil
migrat
locat
respons
microbi
colon
neutrophil
secret
granul
antimicrobi
protein
call
defensin
kill
microb
analysi
cf
sputum
sampl
level
extracellular
defensin
suffici
abund
may
damag
airway
epithelium
soong
et
al
anoth
exampl
interspecif
complex
p
aeruginosa
cf
lung
produc
copiou
amount
tricycl
compound
pyocyanin
kill
compet
microb
eukaryot
cell
compound
shown
specif
inactiv
human
lung
epitheli
cell
line
vacuolar
atpas
ran
et
al
studi
microbiom
lung
conduct
explor
hypothesi
organ
routin
identifi
cultur
occur
lung
cf
patient
airway
may
contribut
diseas
test
hypothesi
rrna
sequenc
analysi
perform
bal
sampl
subject
cf
patient
diseas
control
harri
et
al
find
analysi
cf
subject
singl
rrna
type
dominantli
repres
clone
librari
prepar
lung
microbiom
genom
dna
found
control
thirteen
cf
subject
sampl
contain
bacteria
routin
assess
cultur
candid
pathogen
identifi
four
cf
subject
candid
pathogen
also
identifi
control
studi
document
power
cultureindepend
molecular
techniqu
provid
broader
view
airway
bacteria
standard
clinic
cultur
method
cf
viral
metagenom
explor
recent
studi
use
five
cf
individu
five
individu
without
diseas
willner
et
al
cohort
overal
viral
divers
low
cf
bacteriophag
commun
highli
similar
wherea
noncf
individu
distinct
phage
commun
cf
eukaryot
viral
commun
domin
virus
includ
human
herp
virus
retrovirus
signific
fastidi
noncultivat
organ
airway
cf
patient
begin
explor
applic
specif
cultur
condit
favor
growth
anaerob
coupl
molecular
identif
techniqu
focus
attent
cf
bacteria
routin
detect
standard
cultur
biochem
identif
techniqu
harri
et
al
tunney
et
al
worlitzsch
et
al
direct
cultureindepend
detect
techniqu
identifi
much
larger
number
bacteri
speci
cf
airway
demonstr
abil
identifi
like
pathogen
bacteria
occur
exacerb
routin
cultur
neg
harri
et
al
molecular
identif
detect
method
identifi
bacteria
differ
antibiot
suscept
rel
convent
pathogen
undoubtedli
lead
novel
antimicrobi
intervent
trial
cf
worlitzsch
et
al
similar
methodolog
detect
anaerob
noncultivat
bacteria
appli
systemat
patient
idiopath
bronchiectasi
bronchiectasi
character
chronic
dilat
inflamm
conduct
airway
associ
recur
infect
barker
patholog
manifest
sever
genet
disord
includ
cf
primari
ciliari
dyskinesia
pcd
howev
mani
patient
identifi
caus
idiopath
bronchiectasi
estim
affect
approxim
us
adult
weycker
et
al
symptom
includ
cough
chronic
sputum
product
recur
airway
infect
dyspnea
wheez
chest
pain
barker
microbi
infect
central
pathogenesi
progress
diseas
much
research
character
composit
signific
lower
airway
microbi
flora
done
cf
rel
littl
known
microbi
contribut
diseas
pathogenesi
idiopath
bronchiectasi
howev
recent
observ
suggest
link
lower
airway
microbi
flora
host
diseas
characterist
exampl
preval
idiopath
bronchiectasi
associ
nontubercul
mycobacteria
ntm
appear
increas
billing
et
al
marra
et
al
famili
cluster
characterist
tall
asthen
phenotyp
scoliosi
pectu
excavatum
mitral
valv
abnorm
postmenopaus
women
bronchiectasi
associ
ntm
infect
colombo
et
al
kim
et
al
report
unknown
whether
age
femal
sex
uniqu
bodi
morphotyp
associ
seen
idiopath
bronchiectasi
unassoci
ntm
correl
diseas
phenotyp
microbi
flora
depend
upon
accur
categor
microbi
statu
patient
environment
organ
like
ntm
import
categor
includ
accur
speciat
determin
organ
like
repres
true
infect
rather
contamin
transient
colon
american
thorac
societi
infecti
diseas
societi
america
atsidsa
microbiolog
diagnost
criteria
pulmonari
diseas
base
sputum
specimen
call
least
two
posit
sputum
specimen
speci
kim
et
al
concomit
recoveri
filament
fungi
airway
specimen
also
common
bronchiectasi
pathophysiolog
consequ
known
recent
studi
cf
patient
found
fumigatu
like
ntm
commonli
present
older
patient
patient
age
year
patient
age
valenza
et
al
amin
colleagu
note
cf
patient
chronic
infect
fumigatu
defin
two
posit
cultur
given
year
significantli
wors
airway
obstruct
evidenc
lower
forc
expiratori
volum
one
second
significantli
higher
risk
pulmonari
exacerb
subsequ
followup
patient
without
fumigatu
amin
et
al
potenti
neg
impact
cours
bronchiectasi
possibl
benefit
antifung
treatment
chronic
infect
cf
prompt
initi
multicent
clinic
trial
itraconazol
cf
patient
canada
amin
et
al
shoseyov
et
al
noncf
bronchiectasi
recent
studi
suggest
aspergillu
common
patient
infect
ntm
without
ntm
commonli
associ
fungal
lung
diseas
manifest
ntminfect
patient
kunst
et
al
howev
outsid
rel
small
number
idiopath
bronchiectasi
patient
allerg
bronchopulmonari
aspergillosi
abpa
chronic
necrot
aspergillosi
patholog
signific
fungi
systemat
explor
larg
number
patient
data
avail
aspergillu
speci
fumigatu
filament
fungi
aspergillu
kobashi
et
al
kunst
et
al
raju
et
al
abpa
well
describ
associ
bronchiectasi
occur
asthmat
patient
cf
mald
greenberg
diagnost
criteria
reli
elev
total
ige
well
elev
fumigatusspecif
ige
igg
set
episod
bronchial
obstruct
pulmonari
infiltr
central
bronchiectasi
kunst
colleagu
assess
preval
posit
serolog
marker
fumigatu
ige
radioallergosorb
test
rast
precipitin
among
idiopath
bronchiectasi
patient
found
marker
commonli
present
especi
set
concomit
ntm
diseas
kunst
et
al
patient
serolog
marker
commonli
radiograph
manifest
suggest
aspergillusassoci
diseas
filament
fungi
scedosporium
speci
commonli
recov
airway
cf
noncf
bronchiectasi
patient
role
fungi
play
diseas
pathogenesi
remain
controversi
cooley
et
al
specif
ige
antibodi
rast
precipitin
assay
prepar
use
allergen
prepar
isol
speci
correl
clinic
present
allerg
bronchopulmonari
mycos
assay
commonli
use
character
clinic
signific
fungal
speci
recov
lower
airway
fedorova
et
al
lake
et
al
copd
fourth
lead
caus
death
us
petti
expect
rank
third
world
lopez
murray
despit
effort
aim
smoke
cessat
littl
impact
made
copd
incid
current
treatment
ineffect
slow
progress
diseas
copd
defin
global
initi
chronic
obstruct
lung
diseas
gold
diseas
state
character
airflow
limit
fulli
revers
diagnosi
copd
also
encompass
chronic
obstruct
bronchiol
emphysema
tissu
inflamm
copd
character
predomin
neutrophil
lymphocyt
macrophag
infiltr
keat
et
al
lacost
et
al
shaughnessi
et
al
saetta
et
al
propos
mechan
tissu
damag
involv
recruit
activ
neutrophil
macrophag
cell
concomit
upregul
sever
cellular
proteas
inflammatori
cytokin
although
smoke
clearli
lead
risk
factor
copd
smoker
develop
diseas
buist
connett
smoke
stimul
inflamm
lung
smoker
copd
increas
inflammatori
respons
smoker
without
copd
inflamm
persist
despit
smoke
cessat
keat
et
al
lacost
et
al
shaughnessi
et
al
saetta
et
al
observ
suggest
factor
factor
contribut
develop
perpetu
inflammatori
respons
copd
infect
might
one
factor
critic
trigger
perpetu
inflammatori
respons
copd
mechan
infect
might
act
promot
copd
progress
term
viciou
circl
hypothesi
sethi
sethi
murphi
scenario
smoke
caus
structur
remodel
render
smoker
like
becom
colon
andor
less
abl
clear
subclin
infect
defect
mucociliari
clearanc
surfact
abnorm
caus
smoke
also
contribut
tendenc
develop
chronic
infect
finley
ladman
honda
et
al
raju
et
al
vastag
et
al
verra
et
al
colon
establish
organ
organ
recruit
white
blood
cell
lung
stimul
releas
inflammatori
cytokin
chemokin
well
proteas
inabl
clear
incit
organ
perpetu
cycl
ultim
result
tissu
destruct
airway
thicken
clinic
copd
commonli
implic
bacteria
h
influenza
catarrhali
pneumonia
p
aeruginosa
sethi
virus
seem
import
copd
includ
adenoviru
influenza
virus
rhinoviru
respiratori
syncyti
viru
human
metapneumoviru
mallia
et
al
martinello
et
al
retamal
et
al
seemung
et
al
pathogen
found
patient
copd
stabl
state
exacerb
sethi
colon
seen
patient
copd
like
play
role
diseas
innoc
bystand
exampl
bacteri
load
increas
fall
colon
associ
greater
sputum
purul
increas
sputum
neutrophil
increas
level
interleukin
il
tumor
necrosi
factor
tnf
neutrophil
elastas
obrian
et
al
patel
et
al
sethi
stockley
et
al
exacerb
associ
virus
sever
last
longer
without
viral
trigger
papi
et
al
seemung
et
al
addit
exacerb
associ
bacteria
virus
may
sever
associ
singl
organ
obrian
et
al
suggest
use
metagenom
techniqu
diseas
colon
fungu
pneumocysti
jirovecii
pc
formerli
pneumocysti
carinii
f
sp
homini
recent
implic
copd
pathogenesi
organ
gener
caus
acut
pneumocysti
pneumonia
pcp
patient
immunosuppress
infect
hiv
colon
organ
occur
hiv
individu
may
import
copd
colon
pc
increas
hiv
patient
copd
correl
diseas
sever
morri
et
al
probst
et
al
anim
model
also
support
role
pc
colon
copd
christensen
colleagu
recent
report
immunocompet
mice
exposur
cigarett
smoke
pc
colon
result
pulmonari
function
deficit
airspac
enlarg
characterist
emphysema
christensen
et
al
model
pc
colon
simianhumanimmunodefici
viru
shiv
infect
nonhuman
primat
norri
et
al
pccolon
anim
develop
airway
obstruct
radiograph
emphysema
anim
infect
shiv
alon
develop
chang
shipley
et
al
although
pulmonari
infect
neoplasm
associ
hiv
decreas
sinc
avail
highli
activ
antiretrovir
therapi
haart
palella
et
al
pulmonari
condit
may
actual
increas
person
hiv
diseas
copd
asthma
bronchiectasi
report
increas
hiv
introduct
antiretrovir
therapi
similar
decreas
condit
seen
opportunist
infect
occur
antiretrovir
treatment
hiv
fact
recent
studi
hiv
patient
almost
death
due
obstruct
airway
diseas
threefold
increas
prehaart
era
louie
et
al
haart
era
hiv
subject
note
acceler
form
emphysema
signific
emphysemat
diseas
seen
subject
less
year
old
diaz
et
al
emphysema
airflow
obstruct
report
hiv
infect
unlik
mani
acquir
immunodefici
syndrom
aid
defin
opportunist
infect
hivassoci
copd
may
actual
common
current
era
hiv
frequent
report
without
histori
aidsrel
pulmonari
complic
age
hiv
popul
longer
exposur
smoke
hiv
given
immunolog
defect
seen
hiv
quit
possibl
hiv
subject
especi
smoke
prone
develop
subclin
pulmonari
infect
even
success
treat
haart
chang
occur
lung
microbiom
studi
hiv
microbi
colon
like
factor
acceler
copd
seen
popul
viciou
circl
hypothesi
copd
could
worsen
hiv
patient
upregul
hiv
level
lung
stimul
pulmonari
colon
sever
studi
shown
pulmonari
infect
increas
lung
level
hiv
koziel
colleagu
report
hiv
rna
detect
patient
activ
lung
diseas
compar
asymptomat
subject
independ
clinic
stage
hiv
serum
hiv
rna
level
koziel
et
al
lung
appear
independ
compart
hiv
replic
drug
mutat
found
bal
differ
blood
white
et
al
hiv
lung
associ
lymphocyt
alveol
particularli
subject
cell
count
suggest
viru
might
act
independ
stimul
pulmonari
inflamm
twigg
et
al
relationship
hiv
pulmonari
viral
level
infect
inflamm
copd
examin
pneumocysti
colon
like
import
pathogenesi
copd
hiv
well
hiv
popul
hiv
subject
preval
colon
high
particularli
subject
smoke
colon
seen
even
patient
high
cell
count
receiv
haart
morri
et
al
anatom
emphysema
also
common
hiv
patient
pc
colon
morri
unpublish
data
recent
shown
pneumocysti
colon
hiv
subject
associ
wors
airway
obstruct
increas
likelihood
clinic
diagnosi
copd
independ
smoke
histori
cell
count
morri
et
al
addit
shivinfect
nonhuman
primat
describ
serv
model
develop
copd
set
pc
colon
hivlik
immunodefici
norri
et
al
shipley
et
al
press
microorgan
includ
bacteria
fungi
virus
play
central
role
develop
exacerb
progress
lung
diseas
even
though
normal
lung
perman
resid
microbiom
diseas
lung
acut
infect
andor
chronic
colon
standard
laboratori
practic
properli
reflect
entireti
microbiom
either
health
diseas
thu
newer
sequencebas
technolog
begun
reveal
true
complex
lung
microbiom
much
research
still
need
conduct
order
fulli
understand
microbi
burden
lung
burden
relat
health
diseas
appar
condit
compromis
physic
immun
system
barrier
lung
colon
microb
result
chronic
colon
recurr
infect
condit
includ
chronic
inflamm
seen
hiv
asthma
bronchiecstasi
physic
obstruct
observ
cf
bronchiecstasi
lung
microbiom
condit
properli
explor
date
limit
abil
make
definit
conclus
best
manag
diseas
understand
fundament
role
virus
initi
establish
progress
asthma
underscor
littl
knowledg
exist
role
viral
infect
chronic
respiratori
diseas
addit
fact
bacteri
popul
andor
compon
seem
protect
sever
exacerb
asthma
open
door
question
role
microorgan
protect
diseas
exact
natur
protect
clearli
understood
great
benefit
would
come
studi
clarifi
intrigu
result
furthermor
popul
structur
aid
prevent
diseas
progress
like
popul
structur
may
predispos
episod
acut
acerb
progress
underli
diseas
condit
comprehens
understand
dynam
microbiom
interact
would
like
result
better
effici
therapi
respiratori
diseas
develop
microbiom
analysi
technolog
coupl
increas
awar
potenti
posit
neg
impact
lung
popul
structur
respiratori
system
health
diseas
strongli
support
initi
aggress
project
character
human
lung
microbiom
influenc
health
diseas
